These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25685045)

  • 1. Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery.
    El Maghraby GM; Ahmed AA; Osman MA
    Saudi Pharm J; 2015 Jan; 23(1):67-74. PubMed ID: 25685045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
    Aboelwafa AA; El-Setouhy DA; Elmeshad AN
    AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal Delivery of Nisoldipine: Refinement of Vehicles.
    El Maghraby GM; Ahmed AA; Osman MA
    Int J Pharm Compd; 2015; 19(2):152-60. PubMed ID: 26685495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
    Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
    Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate.
    Varshosaz J; Pardakhty A; Baharanchi SM
    Drug Deliv; 2005; 12(2):75-82. PubMed ID: 15824032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Developments in Proniosomal Transdermal Drug Delivery: An Overview.
    Sabale V; Charde M; Dumore N; Mahajan U
    Curr Drug Deliv; 2023; 20(6):683-693. PubMed ID: 35466874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating transdermal delivery of vitamin D3.
    Alsaqr A; Rasoully M; Musteata FM
    AAPS PharmSciTech; 2015 Aug; 16(4):963-72. PubMed ID: 25609377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Penetration Enhancers on Transdermal Delivery of Oxcarbazepine, an Antiepileptic Drug Using Microemulsions.
    Virani A; Puri V; Mohd H; Michniak-Kohn B
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A statistical experimental design approach to evaluate the influence of various penetration enhancers on transdermal drug delivery of buprenorphine.
    Taghizadeh SM; Moghimi-Ardakani A; Mohamadnia F
    J Adv Res; 2015 Mar; 6(2):155-62. PubMed ID: 25750749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sonophoresis and chemical penetration enhancers on percutaneous transport of penbutolol sulfate.
    Ita KB; Popova IE
    Pharm Dev Technol; 2016 Dec; 21(8):990-995. PubMed ID: 26383739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives.
    Trimble JO; Light B
    Int J Pharm Compd; 2017; 21(6):530-535. PubMed ID: 29220342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro skin permeation of estradiol from various proniosome formulations.
    Fang JY; Yu SY; Wu PC; Huang YB; Tsai YH
    Int J Pharm; 2001 Mar; 215(1-2):91-9. PubMed ID: 11250095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application.
    Nemr AA; El-Mahrouk GM; Badie HA
    Drug Dev Ind Pharm; 2021 Mar; 47(3):403-415. PubMed ID: 33625936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proniosomes in transdermal drug delivery.
    Rahimpour Y; Kouhsoltani M; Hamishehkar H
    Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occlusive and non-occlusive application of microemulsion for transdermal delivery of progesterone: mechanistic studies.
    El Maghraby GM
    Sci Pharm; 2012; 80(3):765-78. PubMed ID: 23008820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.